Recludix Pharma

Operator of a drug discovery company intended to treat cancer and autoimmune diseases. The company combines deoxyribonucleic acid encoded libraries, parallel structure-activity relationship determination, and proprietary screening tools to identify and develop potent and selective inhibitors of challenging protein targets, enabling medical professionals to treat cancer effectively and with greater precision.

New Enterprise Associates

🏥 Healthcare